3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
Public ClinicalTrials.gov record NCT00312494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex
Study identification
- NCT ID
- NCT00312494
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Ziprasidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2006
- Primary completion
- Nov 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Mar 28, 2021
2006 – 2008
United States locations
- U.S. sites
- 66
- U.S. states
- 25
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Dothan | Alabama | 36303 | — |
| Pfizer Investigational Site | Scottsdale | Arizona | 85251 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72211 | — |
| Pfizer Investigational Site | Cerritos | California | 90703 | — |
| Pfizer Investigational Site | Costa Mesa | California | 92626 | — |
| Pfizer Investigational Site | Escondido | California | 92025 | — |
| Pfizer Investigational Site | Glendale | California | 91204 | — |
| Pfizer Investigational Site | Huntington Beach | California | 92647 | — |
| Pfizer Investigational Site | Los Angeles | California | 90057 | — |
| Pfizer Investigational Site | Los Angeles | California | 90061 | — |
| Pfizer Investigational Site | National City | California | 91950 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | San Diego | California | 92114 | — |
| Pfizer Investigational Site | San Diego | California | 92120 | — |
| Pfizer Investigational Site | San Diego | California | 92126 | — |
| Pfizer Investigational Site | Torrance | California | 90505 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06106 | — |
| Pfizer Investigational Site | New Britain | Connecticut | 06050 | — |
| Pfizer Investigational Site | DeLand | Florida | 32720 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33301 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32607 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32256-2006 | — |
| Pfizer Investigational Site | Lauderhill | Florida | 33119 | — |
| Pfizer Investigational Site | North Miami | Florida | 33161 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Honolulu | Hawaii | 96813 | — |
| Pfizer Investigational Site | Des Plaines | Illinois | 60016 | — |
| Pfizer Investigational Site | Hoffman Estates | Illinois | 60169 | — |
| Pfizer Investigational Site | Hoffman Estates | Illinois | 60194 | — |
| Pfizer Investigational Site | Schaumburg | Illinois | 60194 | — |
| Pfizer Investigational Site | Greenwood | Indiana | 46143 | — |
| Pfizer Investigational Site | Prairie Village | Kansas | 66206 | — |
| Pfizer Investigational Site | Glen Burnie | Maryland | 21061 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64133 | — |
| Pfizer Investigational Site | Saint Charles | Missouri | 63304 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63044-2588 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63118 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63128 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89103 | — |
| Pfizer Investigational Site | Clementon | New Jersey | 08021 | — |
| Pfizer Investigational Site | Princeton | New Jersey | 08540 | — |
| Pfizer Investigational Site | Amityville | New York | 11701 | — |
| Pfizer Investigational Site | Buffalo | New York | 14215 | — |
| Pfizer Investigational Site | Cedarhurst | New York | 11516 | — |
| Pfizer Investigational Site | Elmsford | New York | 10523 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45220 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0559 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44113 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19149 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29405 | — |
| Pfizer Investigational Site | Dallas | Texas | 75228 | — |
| Pfizer Investigational Site | Irving | Texas | 75062 | — |
| Pfizer Investigational Site | Plano | Texas | 75024 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229-3900 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78259-3509 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23230 | — |
| Pfizer Investigational Site | Bellevue | Washington | 98004 | — |
| Pfizer Investigational Site | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00312494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2021 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00312494 live on ClinicalTrials.gov.